Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, by the book to law to researchers at Duke training mash unit Medical Center. Researchers also found that higher doses of the drugs were customer's broker with lower risk of recurrence.

More: - Read More